Key result
Geometric mitral regurgitation can improve with antiremodeling therapies and surgical repair, though survival benefits remain uncertain and percutaneous approaches are still experimental.
Geometric mitral regurgitation in the setting of cardiomyopathy can be managed with antiremodeling therapies and surgery to improve symptoms, though the survival benefits of surgery remain uncertain and percutaneous approaches are still experimental.
May support antiremodeling for symptom relief in geometric MR; leaves open survival benefit of surgery and percutaneous options.
PURPOSE OF REVIEW: Geometric mitral regurgitation is a phenomenon encountered by an otherwise anatomically normal mitral valve in the setting of advanced adverse left ventricular remodeling that alters the alignment characteristics of the mitral valve apparatus leading to functional production of a leaking valve. In this review, we discuss contemporary directions in the knowledge base for managing geometric mitral regurgitation. RECENT FINDINGS: Much progress has been encountered in describing the types of geometric mitral regurgitation (nonischemic and ischemic origins), standardization of echocardiographic techniques to allow for a common language in ascertaining the severity of mitral regurgitation, knowledge on dynamic mitral regurgitation during exercise, effectiveness of therapy and appropriate use and timing of surgical repair. SUMMARY: Geometric mitral regurgitation develops in tandem with progressive ischemic or nonischemic cardiomyopathy and can improve with antiremodeling pharmacological and device-based therapy. Surgical therapy can be accomplished at experienced centers with low morbidity and mortality, and may improve symptoms and enhance pump function. Whether such therapy saves lives remains uncertain. New percutaneous approaches to tackle geometric mitral regurgitation are developing, and early data is encouraging but remains experimental.
No takes yet. Share an insight, caveat, or question.
Mehra et al. (2009) conducted a review in Geometric mitral regurgitation and cardiomyopathy. Management strategies (pharmacological, device-based, surgical, percutaneous) was evaluated. Geometric mitral regurgitation can improve with antiremodeling therapies and surgical repair, though survival benefits remain uncertain and percutaneous approaches are still experimental.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: